share_log

AIM ImmunoTech Q4 EPS $(0.26) Misses $(0.15) Estimate, Sales $65.00K Beat $40.00K Estimate

AIM ImmunoTech Q4 EPS $(0.26) Misses $(0.15) Estimate, Sales $65.00K Beat $40.00K Estimate

AIM ImmunoTech第四季度每股收益美元(0.26美元)未達到預期(0.15美元),銷售額超過40.00萬美元的預期
Benzinga ·  04/02 22:58

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.15) by 73.33 percent. This is a 188.89 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $65.00 thousand which beat the analyst consensus estimate of $40.00 thousand by 62.50 percent. This is a 16.07 percent increase over sales of $56.00 thousand the same period last year.

AIM ImmunoTech(美國證券交易所股票代碼:AIM)公佈的季度虧損爲每股0.26美元,比分析師普遍預期的0.15美元(0.15美元)低73.33%。與去年同期每股虧損0.09美元(0.09)相比,下降了188.89%。該公司公佈的季度銷售額爲65,000美元,比分析師普遍預期的4萬美元高出62.50%。這比去年同期的56,000美元的銷售額增長了16.07%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論